Skip to main content
Scott Furlan, MD, Pediatric Hematology & Oncology, Seattle, WA

Scott Nicholas Furlan MD


Assistant Professor

Join to View Full Profile
  • 1100 Olive WaySte 100Seattle, WA 98101

  • Phone+1 206-884-4053

Dr. Furlan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Scott Furlan is a pediatric hematologist/oncologist at the Fred Hutchinson Cancer Center in Seattle, WA and is affiliated with Seattle Children's Hospital. He received his medical degree from University of Southern California School of Medicine and has been in practice 15 years. He is experienced in transplant immunology, tumor immunology, adoptive immunotherapy, omics, and regulatory t-lymphocytes. He has more than 20 publications and over 500 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pediatrics, 2006 - 2009
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - Present
  • WA State Medical License
    WA State Medical License 2013 - 2026
  • TX State Medical License
    TX State Medical License 2008 - 2013
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Lectures

  • IL2 and Rapamycin Enhance Persistence of Adoptively-Transferred Ex-Vivo Expanded T Regulatory Cells 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric Leukemia
    BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric LeukemiaFebruary 28th, 2022

Professional Memberships

Other Languages

  • Spanish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: